» Articles » PMID: 32751786

Models Contribution to the Understanding of Sarcoidosis Pathogenesis: "Are There Good Models of Sarcoidosis?"

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Aug 6
PMID 32751786
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcoidosis is a systemic, granulomatous, and noninfectious disease of unknown etiology. The clinical heterogeneity of the disease (targeted tissue(s), course of the disease, and therapy response) supports the idea that a multiplicity of trigger antigens may be involved. The pathogenesis of sarcoidosis is not yet completely understood, although in recent years, considerable efforts were put to develop novel experimental research models of sarcoidosis. In particular, sarcoidosis patient cells were used within in vitro 3D models to study their characteristics compared to control patients. Likewise, a series of transgenic mouse models were developed to highlight the role of particular signaling pathways in granuloma formation and persistence. The purpose of this review is to put in perspective the contributions of the most recent models in the understanding of sarcoidosis.

Citing Articles

Navigating Challenges in a Case of Unusual Hepatic and Pulmonar Sarcoidosis: A Comprehensive Clinical Journey.

Goncalves A, Simas D, Gomes P, Leal C, Atalaia-Martins C, Vasconcelos H GE Port J Gastroenterol. 2025; 32(1):61-66.

PMID: 39906510 PMC: 11790262. DOI: 10.1159/000539226.


Advance in pathogenesis of sarcoidosis: Triggers and progression.

Chen C, Luo N, Dai F, Zhou W, Wu X, Zhang J Heliyon. 2024; 10(5):e27612.

PMID: 38486783 PMC: 10938127. DOI: 10.1016/j.heliyon.2024.e27612.


An mTORC1-Dependent Mouse Model for Cardiac Sarcoidosis.

Bueno-Beti C, Lim C, Protonotarios A, Szabo P, Westaby J, Mazic M J Am Heart Assoc. 2023; 12(19):e030478.

PMID: 37750561 PMC: 10727264. DOI: 10.1161/JAHA.123.030478.


Pulmonary Sarcoidosis: Experimental Models and Perspectives of Molecular Diagnostics Using Quantum Dots.

Linkova N, Diatlova A, Zinchenko Y, Kornilova A, Snetkov P, Morozkina S Int J Mol Sci. 2023; 24(14).

PMID: 37511027 PMC: 10379333. DOI: 10.3390/ijms241411267.


Sarcoidosis and Autoimmune Inflammatory Syndrome Induced by Adjuvants.

Starshinova A, Zinchenko Y, Malkova A, Kudlay D, Kudryavtsev I, Yablonskiy P Life (Basel). 2023; 13(4).

PMID: 37109576 PMC: 10145559. DOI: 10.3390/life13041047.


References
1.
Rossides M, Grunewald J, Eklund A, Kullberg S, Di Giuseppe D, Askling J . Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study. Eur Respir J. 2018; 52(2). DOI: 10.1183/13993003.00385-2018. View

2.
Chen E, Wahlstrom J, Song Z, Willett M, Wiken M, Yung R . T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol. 2008; 181(12):8784-96. PMC: 2700300. DOI: 10.4049/jimmunol.181.12.8784. View

3.
Ursini C, Maiello R, Ciervo A, Fresegna A, Buresti G, Superti F . Evaluation of uptake, cytotoxicity and inflammatory effects in respiratory cells exposed to pristine and -OH and -COOH functionalized multi-wall carbon nanotubes. J Appl Toxicol. 2015; 36(3):394-403. DOI: 10.1002/jat.3228. View

4.
Sverrild A, Backer V, Kyvik K, Kaprio J, Milman N, Svendsen C . Heredity in sarcoidosis: a registry-based twin study. Thorax. 2008; 63(10):894-6. DOI: 10.1136/thx.2007.094060. View

5.
Barna B, Huizar I, Malur A, McPeek M, Marshall I, Jacob M . Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation. Int J Mol Sci. 2013; 14(12):23858-71. PMC: 3876082. DOI: 10.3390/ijms141223858. View